Double maintains 4 strategies that include ROIV - Roivant Sciences Ltd.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IMVT | 60.81% | $2.36B | -55.78% | 0.00% |
CRNX | 52.86% | $2.92B | -39.88% | 0.00% |
ACLX | 52.78% | $3.22B | +10.72% | 0.00% |
BN | 52.49% | $98.39B | +33.78% | 0.55% |
BNT | 51.10% | $11.98B | +33.22% | 0.00% |
KYMR | 51.07% | $1.95B | -15.67% | 0.00% |
KRYS | 50.16% | $3.77B | -20.42% | 0.00% |
CRH | 49.94% | $66.31B | +18.04% | 0.00% |
ENTG | 49.53% | $11.89B | -39.86% | 0.52% |
LGND | 49.33% | $2.00B | +21.70% | 0.00% |
IDYA | 48.67% | $1.52B | -58.32% | 0.00% |
MFA | 48.65% | $1.01B | -10.64% | 14.30% |
RCKT | 48.44% | $724.54M | -71.26% | 0.00% |
APH | 48.32% | $103.99B | +30.54% | 0.70% |
AMKR | 48.16% | $4.92B | -38.62% | 1.63% |
IONS | 48.02% | $5.25B | -12.31% | 0.00% |
PH | 47.85% | $85.95B | +24.68% | 0.99% |
BLK | 47.46% | $152.30B | +21.71% | 2.09% |
DNLI | 47.40% | $2.06B | -30.04% | 0.00% |
GS | 47.35% | $188.98B | +32.59% | 1.90% |
Current Value
$10.751 Year Return
Current Value
$10.751 Year Return
Yahoo
BASEL, Switzerland and LONDON and NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 29, 2025, to report its financial results for the fourth quarter and fiscal year ended March 31, 2025, and provide a business update. To access the conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under “Even
Finnhub
Presenter SpeechJason Gerberry We're going with our next company presenter at the BofA Annual Healthcare Conference. I am pleased to be introducing Roivant and Chief Executive Officer, Matt Gline.
SeekingAlpha
Roivant Sciences: Primed For Growth With A De-Risked Pipeline
Yahoo
Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.
Yahoo
Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.
Yahoo
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of ImmunovantPete Salzmann, M.D. retired from his role as Immunovant CEO and DirectorLeadership change is part of a broader strategic transition with Roivant increasing operational involvement and strategic oversight of Immunovant IND cleared for a potentially registrational program for IMVT-1402 in SjD, its fifth and potentially best-in-class indication with positive in-cla
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PRPO | -0.03% | $10.84M | +15.14% | 0.00% |
ED | -0.10% | $36.75B | +5.26% | 3.28% |
FUBO | 0.17% | $1.01B | +121.80% | 0.00% |
TU | 0.18% | $23.77B | -4.62% | 7.19% |
ASPS | 0.21% | $69.98M | -57.72% | 0.00% |
IRWD | 0.22% | $96.19M | -91.05% | 0.00% |
CYCN | 0.22% | $9.37M | +2.39% | 0.00% |
AQB | 0.23% | $2.96M | -61.58% | 0.00% |
LTM | -0.24% | $11.01B | -96.75% | 2.75% |
QXO | 0.24% | $8.44B | -84.99% | 0.00% |
K | -0.36% | $28.49B | +32.17% | 2.77% |
VSTA | 0.39% | $326.82M | +11.64% | 0.00% |
VHC | -0.44% | $34.69M | +74.89% | 0.00% |
OCFT | -0.48% | $265.28M | +232.26% | 0.00% |
DADA | 0.50% | $526.11M | +11.54% | 0.00% |
OXBR | 0.62% | $14.89M | +14.29% | 0.00% |
DOGZ | -0.66% | $231.95M | +120.05% | 0.00% |
MSEX | 0.67% | $1.02B | -1.01% | 2.34% |
BPT | -0.68% | $13.70M | -73.66% | 0.00% |
AGL | -1.01% | $1.06B | -54.30% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 69.39% | $4.85B | 0.35% |
IBB | 66.52% | $5.22B | 0.45% |
BBH | 61.22% | $327.42M | 0.35% |
FBT | 61.16% | $994.71M | 0.56% |
PBE | 60.37% | $214.12M | 0.58% |
GNOM | 59.66% | $40.65M | 0.5% |
XT | 59.29% | $3.24B | 0.46% |
QQQJ | 58.62% | $610.08M | 0.15% |
PTH | 58.57% | $96.56M | 0.6% |
JQUA | 58.24% | $6.06B | 0.12% |
CGBL | 58.16% | $2.14B | 0.33% |
SUSA | 58.04% | $3.48B | 0.25% |
DUHP | 57.94% | $8.05B | 0.21% |
AOA | 57.89% | $2.30B | 0.15% |
URTH | 57.81% | $4.73B | 0.24% |
VT | 57.78% | $45.29B | 0.06% |
SPGM | 57.73% | $1.04B | 0.09% |
FQAL | 57.69% | $1.04B | 0.16% |
ACWI | 57.65% | $21.24B | 0.32% |
ITOT | 57.62% | $67.14B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -8.11% | $45.74M | -99.96% | 0.00% |
VSA | -7.69% | $7.04M | -49.24% | 0.00% |
CBOE | -6.76% | $22.95B | +20.67% | 1.12% |
LITB | -6.65% | $21.28M | -72.45% | 0.00% |
SYPR | -5.17% | $37.69M | +21.48% | 0.00% |
STG | -5.01% | $27.05M | -37.35% | 0.00% |
EXC | -4.83% | $43.84B | +12.45% | 3.59% |
PSQH | -4.23% | $89.26M | -49.87% | 0.00% |
UUU | -3.13% | $4.93M | +40.20% | 0.00% |
NEUE | -2.98% | $62.05M | +13.56% | 0.00% |
CCRN | -2.75% | $457.33M | -5.30% | 0.00% |
CATO | -2.57% | $54.69M | -48.22% | 12.06% |
ZCMD | -1.38% | $32.45M | -11.38% | 0.00% |
AGL | -1.01% | $1.06B | -54.30% | 0.00% |
BPT | -0.68% | $13.70M | -73.66% | 0.00% |
DOGZ | -0.66% | $231.95M | +120.05% | 0.00% |
OCFT | -0.48% | $265.28M | +232.26% | 0.00% |
VHC | -0.44% | $34.69M | +74.89% | 0.00% |
K | -0.36% | $28.49B | +32.17% | 2.77% |
LTM | -0.24% | $11.01B | -96.75% | 2.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -46.11% | $109.64M | 0.85% |
TAIL | -45.00% | $140.49M | 0.59% |
BTAL | -37.49% | $361.41M | 1.43% |
IVOL | -14.52% | $353.94M | 1.02% |
KCCA | -12.84% | $97.18M | 0.87% |
XHLF | -12.82% | $1.46B | 0.03% |
FTSD | -12.37% | $212.46M | 0.25% |
FXY | -12.29% | $838.61M | 0.4% |
TFLO | -11.45% | $7.06B | 0.15% |
ULST | -9.64% | $637.77M | 0.2% |
BIL | -8.92% | $45.95B | 0.1356% |
TPMN | -8.42% | $31.54M | 0.65% |
SPTS | -7.78% | $5.76B | 0.03% |
XONE | -7.73% | $603.24M | 0.03% |
TBLL | -7.52% | $2.46B | 0.08% |
BILS | -7.13% | $3.96B | 0.1356% |
GBIL | -6.96% | $6.17B | 0.12% |
CLIP | -5.90% | $1.50B | 0.07% |
SCHO | -5.70% | $10.87B | 0.03% |
IBTG | -4.61% | $1.88B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UUP | -0.08% | $292.27M | 0.77% |
UNG | 0.31% | $371.83M | 1.06% |
LDUR | -0.41% | $849.09M | 0.5% |
SHV | -0.49% | $20.94B | 0.15% |
FXE | -0.56% | $525.40M | 0.4% |
IBTI | -0.73% | $995.39M | 0.07% |
CTA | -0.74% | $1.05B | 0.76% |
UDN | 0.75% | $137.74M | 0.78% |
AGGH | 0.79% | $309.35M | 0.29% |
IBTJ | 0.80% | $658.04M | 0.07% |
CARY | -0.85% | $347.36M | 0.8% |
IBTK | 1.08% | $431.59M | 0.07% |
IEI | 1.12% | $16.09B | 0.15% |
USDU | -1.27% | $173.44M | 0.5% |
STPZ | -1.41% | $446.46M | 0.2% |
IBTH | -1.51% | $1.53B | 0.07% |
BUXX | 1.72% | $284.43M | 0.25% |
USFR | 1.77% | $18.91B | 0.15% |
PULS | 1.85% | $11.17B | 0.15% |
WEAT | 1.95% | $115.83M | 0.28% |